Research programme: small molecule therapeutics - Bionaut Pharmaceuticals

Drug Profile

Research programme: small molecule therapeutics - Bionaut Pharmaceuticals

Alternative Names: BNC-1; BNC-2; BNC-3; BNC-4; BNI-01

Latest Information Update: 03 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bionaut Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Inflammation; Macular degeneration

Most Recent Events

  • 11 Oct 2005 Compounds from this programme are available for licensing (http://www.bionautpharma.com)
  • 11 Oct 2005 Preclinical trials in Inflammation in USA (unspecified route)
  • 11 Oct 2005 Preclinical trials in Macular degeneration in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top